Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products

. 2015 Aug ; 40 (8) : 1709-18. [epub] 20150719

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid26189181

It has been suggested that advanced glycation end (AGE) products, via cognate receptor activation, are implicated in several diseases, including Alzheimer's disease. The NMDA receptor-nitric oxide pathway appears to be influenced by AGE products and involved in the pathogenesis of this type of dementia. In this study, C57BL/6J (WT) and transgenic (Tg2576) mice expressing human mutant amyloid precursor protein were kept on prolonged (8 months) diets containing regular or high amounts of AGE products. After the decapitation of 11-months old mice, brain tissue analyses were performed [expressions of the NR1, NR2A and NR2B subunits of NMDA receptors, activities of neuronal, endothelial and inducible nitric oxide synthase (nNOS, eNOS and iNOS)]. Moreover, levels of malondialdehyde and of human amyloid β 1-42 were estimated. We found increased activity of nNOS in WT mice maintained on a high compared to regular AGE diet; however, no similar differences were found in Tg2576 mice. In addition, we observed an increase in NR1 expression in Tg2576 compared to WT mice, both kept on a diet high in AGE products. Correlation analyses performed on mice kept on the regular AGE diet supported close links between particular subunits (NR2A-NR2B, in WT as well as in Tg2576 mice), between subunits and synthase (NR2A/NR2B-nNOS, only in WT mice) or between particular synthases (nNOS-iNOS, only in WT). Correlation analysis also revealed differences between WT mice kept on both diets (changed correlations between NR2A/NR2B-nNOS, between nNOS-eNOS and between eNOS-iNOS). Malondialdehyde levels were increased in both Tg2576 groups when compared to the corresponding WT mice, but no effects of the diets were observed. Analogously, no significant effects of diets were found in the levels of soluble or insoluble amyloid β 1-42 in Tg2576 mice. Our results demonstrate that prolonged ingestion of AGE products can influence the NMDA receptor-nitric oxide pathway in the brain and that only WT mice, not Tg2576 mice, are able to maintain homeostasis among subunits and synthases or among particular synthases. The prolonged application of AGE products enhanced differences between 11-months old Tg2576 and WT mice regarding this pathway. Observed differences in the pathway between WT mice kept on regular or high AGE diets suggest that the prolonged application of a diet low in AGE products could have beneficial effects in older or diabetic people and perhaps also in people with Alzheimer's disease.

Zobrazit více v PubMed

Mech Ageing Dev. 2014 Sep;140:10-2 PubMed

Neurobiol Aging. 2011 May;32(5):763-77 PubMed

Aging Cell. 2016 Apr;15(2):309-16 PubMed

Science. 1996 Oct 4;274(5284):99-102 PubMed

Eur Arch Psychiatry Neurol Sci. 1990;239(5):314-9 PubMed

Neurochem Res. 2015 Apr;40(4):713-22 PubMed

J Clin Biochem Nutr. 2010 Mar;46(2):177-85 PubMed

Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H315-23 PubMed

Neurobiol Aging. 2001 May-Jun;22(3):397-402 PubMed

J Transl Med. 2009 Mar 17;7:17 PubMed

J Chromatogr A. 2001 Jul 6;921(2):237-45 PubMed

Acta Neurol Scand. 2007 Dec;116(6):368-73 PubMed

Neurosci Lett. 2001 Apr 20;302(2-3):73-6 PubMed

Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):308-15 PubMed

Atherosclerosis. 2013 Aug;229(2):287-94 PubMed

Urology. 1997 Dec;50(6):1016-26 PubMed

J Neurochem. 2008 Oct;107(1):279-90 PubMed

Lipids Health Dis. 2011 Dec 06;10:228 PubMed

Front Behav Neurosci. 2013 Aug 12;7:90 PubMed

Proc Natl Acad Sci U S A. 1994 Jun 7;91(12 ):5710-4 PubMed

Neuropharmacology. 2013 Jan;64:13-26 PubMed

Neurogastroenterol Motil. 2008 Mar;20(3):253-61 PubMed

J Alzheimers Dis. 2009;16(4):833-43 PubMed

J Neural Transm (Vienna). 2006 Nov;113(11):1671-7 PubMed

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766-70 PubMed

J Neurosci. 2010 Apr 28;30(17 ):5948-57 PubMed

Diabetologia. 2004 Feb;47(2):331-9 PubMed

Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6434-8 PubMed

Neuroscience. 2015 Apr 2;290:530-42 PubMed

Neuroscience. 2013 Oct 10;250:565-77 PubMed

Am J Physiol Renal Physiol. 2003 Jun;284(6):F1121-37 PubMed

Neurogastroenterol Motil. 2006 May;18(5):392-400 PubMed

Neuroscience. 2004;128(1):73-89 PubMed

Mol Cell Biochem. 2006 Feb;283(1-2):129-37 PubMed

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):121-6 PubMed

Neurochem Int. 2008 Nov;53(5):118-25 PubMed

Nature. 1996 Aug 22;382(6593):685-91 PubMed

Altern Med Rev. 2009 Dec;14(4):373-9 PubMed

Cardiovasc Res. 2012 Dec 1;96(3):504-12 PubMed

Neuroscience. 2013 Oct 10;250:140-50 PubMed

Int J Dev Neurosci. 2003 Nov;21(7):357-69 PubMed

Neurogastroenterol Motil. 2011 Oct;23(10):964-e411 PubMed

Int J Dev Neurosci. 2004 Nov;22(7):475-84 PubMed

Cereb Cortex. 2005 Feb;15(2):211-20 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...